Follow the people · Insider
Atul Dandekar
Atul Dandekar files insider transactions with the SEC as a csbo of Maze Therapeutics (MAZE). We hold 10 disclosed purchases and sales filed since 24 September 2025, 5 of them in the last 90 days.
- Files forMAZE
- Disclosed buys and sells10 in all, 5 in the last 90 days
- Last disclosure4 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 22 September 2025 — 3 September 2026Csbo · Maze Therapeutics (MAZE)60 Form 4 lines · source: SEC Form 4
Everything they disclosed
60 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 2,800 shares of Maze TherapeuticsSEC Form 44 September 2026Common Stock · traded 2 September 2026 · filed 4 September 2026
- ▼ sold on the open market 391 shares of Maze TherapeuticsSEC Form 44 September 2026Common Stock · traded 2 September 2026 · filed 4 September 2026
- ▼ sold on the open market 3,207 shares of Maze TherapeuticsSEC Form 44 September 2026Common Stock · traded 3 September 2026 · filed 4 September 2026
- ▼ sold on the open market 36 shares of Maze TherapeuticsSEC Form 44 September 2026Common Stock · traded 3 September 2026 · filed 4 September 2026
- exercised options over 12,500 shares of Maze TherapeuticsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- exercised options over 12,500 shares of Maze Therapeutics (a derivative holding)SEC Form 43 September 2026Restricted Stock Units · traded 1 September 2026 · filed 3 September 2026
- exercised options over 7,500 shares of Maze TherapeuticsSEC Form 431 August 2026Common Stock · traded 28 August 2026 · filed 31 August 2026
- ▼ sold on the open market 7,500 shares of Maze TherapeuticsSEC Form 431 August 2026Common Stock · traded 28 August 2026 · filed 31 August 2026
- exercised options over 7,500 shares of Maze Therapeutics (a derivative holding)SEC Form 431 August 2026Stock Option (Right to Buy) · traded 28 August 2026 · filed 31 August 2026
- exercised options over 7,500 shares of Maze TherapeuticsSEC Form 431 July 2026Common Stock · traded 29 July 2026 · filed 31 July 2026
- ▼ sold on the open market 7,100 shares of Maze TherapeuticsSEC Form 431 July 2026Common Stock · traded 29 July 2026 · filed 31 July 2026
- ▼ sold on the open market 400 shares of Maze TherapeuticsSEC Form 431 July 2026Common Stock · traded 29 July 2026 · filed 31 July 2026
- exercised options over 7,500 shares of Maze Therapeutics (a derivative holding)SEC Form 431 July 2026Stock Option (Right to Buy) · traded 29 July 2026 · filed 31 July 2026
- exercised options over 7,500 shares of Maze TherapeuticsSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 7,500 shares of Maze TherapeuticsSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- exercised options over 7,500 shares of Maze Therapeutics (a derivative holding)SEC Form 41 July 2026Stock Option (Right to Buy) · traded 29 June 2026 · filed 1 July 2026
- exercised options over 7,500 shares of Maze TherapeuticsSEC Form 42 June 2026Common Stock · traded 29 May 2026 · filed 2 June 2026
- ▼ sold on the open market 7,500 shares of Maze TherapeuticsSEC Form 42 June 2026Common Stock · traded 29 May 2026 · filed 2 June 2026
- exercised options over 7,500 shares of Maze Therapeutics (a derivative holding)SEC Form 42 June 2026Stock Option (Right to Buy) · traded 29 May 2026 · filed 2 June 2026
- exercised options over 8,320 shares of Maze TherapeuticsSEC Form 46 May 2026Common Stock · traded 4 May 2026 · filed 6 May 2026
- exercised options over 5,985 shares of Maze TherapeuticsSEC Form 46 May 2026Common Stock · traded 4 May 2026 · filed 6 May 2026
- exercised options over 8,320 shares of Maze Therapeutics (a derivative holding)SEC Form 46 May 2026Stock Option (Right to Buy) · traded 4 May 2026 · filed 6 May 2026
- exercised options over 5,985 shares of Maze Therapeutics (a derivative holding)SEC Form 46 May 2026Stock Option (Right to Buy) · traded 4 May 2026 · filed 6 May 2026
- exercised options over 7,500 shares of Maze TherapeuticsSEC Form 41 May 2026Common Stock · traded 29 April 2026 · filed 1 May 2026
- ▼ sold on the open market 7,500 shares of Maze TherapeuticsSEC Form 41 May 2026Common Stock · traded 29 April 2026 · filed 1 May 2026
- exercised options over 7,500 shares of Maze Therapeutics (a derivative holding)SEC Form 41 May 2026Stock Option (Right to Buy) · traded 29 April 2026 · filed 1 May 2026
- exercised options over 7,500 shares of Maze TherapeuticsSEC Form 41 April 2026Common Stock · traded 30 March 2026 · filed 1 April 2026
- ▼ sold on the open market 6,710 shares of Maze TherapeuticsSEC Form 41 April 2026Common Stock · traded 30 March 2026 · filed 1 April 2026
- ▼ sold on the open market 790 shares of Maze TherapeuticsSEC Form 41 April 2026Common Stock · traded 30 March 2026 · filed 1 April 2026
- exercised options over 7,500 shares of Maze Therapeutics (a derivative holding)SEC Form 41 April 2026Stock Option (Right to Buy) · traded 30 March 2026 · filed 1 April 2026
- exercised options over 7,500 shares of Maze TherapeuticsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 3,739 shares of Maze TherapeuticsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 3,761 shares of Maze TherapeuticsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- exercised options over 7,500 shares of Maze Therapeutics (a derivative holding)SEC Form 43 March 2026Stock Option (Right to Buy) · traded 27 February 2026 · filed 3 March 2026
- was granted 38,000 shares of Maze Therapeutics (a derivative holding)SEC Form 43 March 2026Stock Option (Right to Buy) · traded 2 March 2026 · filed 3 March 2026
- was granted 19,000 shares of Maze Therapeutics (a derivative holding)SEC Form 43 March 2026Restricted Stock Units · traded 2 March 2026 · filed 3 March 2026
- exercised options over 7,500 shares of Maze Therapeutics (a derivative holding)SEC Form 43 March 2026Stock Option (Right to Buy) · traded 27 February 2026 · filed 3 March 2026
- was granted 38,000 shares of Maze Therapeutics (a derivative holding)SEC Form 43 March 2026Stock Option (Right to Buy) · traded 2 March 2026 · filed 3 March 2026
- was granted 19,000 shares of Maze Therapeutics (a derivative holding)SEC Form 43 March 2026Restricted Stock Units · traded 2 March 2026 · filed 3 March 2026
- exercised options over 7,500 shares of Maze TherapeuticsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 3,739 shares of Maze TherapeuticsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- ▼ sold on the open market 3,761 shares of Maze TherapeuticsSEC Form 43 March 2026Common Stock · traded 27 February 2026 · filed 3 March 2026
- exercised options over 7,500 shares of Maze TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 1,200 shares of Maze TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 3,500 shares of Maze TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- exercised options over 7,500 shares of Maze Therapeutics (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 2,800 shares of Maze TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- exercised options over 7,500 shares of Maze Therapeutics (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 29 January 2026 · filed 2 February 2026
- exercised options over 7,500 shares of Maze TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 1,200 shares of Maze TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 3,500 shares of Maze TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 2,800 shares of Maze TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- exercised options over 72,400 shares of Maze Therapeutics (a derivative holding)SEC Form 431 December 2025Stock Option (Right to Buy) · traded 29 December 2025 · filed 31 December 2025
- exercised options over 100 shares of Maze Therapeutics (a derivative holding)SEC Form 431 December 2025Stock Option (Right to Buy) · traded 30 December 2025 · filed 31 December 2025
- exercised options over 72,400 shares of Maze TherapeuticsSEC Form 431 December 2025Common Stock · traded 29 December 2025 · filed 31 December 2025
- ▼ sold on the open market 66,365 shares of Maze TherapeuticsSEC Form 431 December 2025Common Stock · traded 29 December 2025 · filed 31 December 2025
- ▼ sold on the open market 6,035 shares of Maze TherapeuticsSEC Form 431 December 2025Common Stock · traded 29 December 2025 · filed 31 December 2025
- exercised options over 100 shares of Maze TherapeuticsSEC Form 431 December 2025Common Stock · traded 30 December 2025 · filed 31 December 2025
- ▼ sold on the open market 100 shares of Maze TherapeuticsSEC Form 431 December 2025Common Stock · traded 30 December 2025 · filed 31 December 2025
- was granted 25,000 shares of Maze Therapeutics (a derivative holding)SEC Form 424 September 2025Restricted Stock Units · traded 22 September 2025 · filed 24 September 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.